A-Part Gel, an adhesion prophylaxis for abdominal surgery: a randomized controlled phase I-II safety study...

Area of Science:

• Surgical innovation
• Adhesion prevention
• Clinical trial methodology

Background:

• Intra-abdominal surgery frequently leads to intra-peritoneal adhesions, a common postsurgical complication.
• Existing adhesion prophylaxis methods are suboptimal, necessitating novel solutions.
• A-Part Gel was developed as a barrier to mitigate postsurgical adhesions.

Purpose of the Study:

• To evaluate the safety and efficacy of A-Part Gel as an adhesion prophylaxis.
• To assess the impact of A-Part Gel on postsurgical complications like peritonitis and wound healing.
• To determine the incidence of anastomotic leakage and adverse events.

Main Methods:

• A prospective, randomized, patient-blinded, monocenter phase I-II study involving 62 patients undergoing elective median laparotomy.
• Patients received either A-Part Gel or no treatment (control group).
• Primary endpoints included peritonitis and wound healing impairment; secondary endpoints were anastomotic leakage, adverse events, and adhesion rates.

Main Results:

• A lower incidence of wound healing impairment and/or peritonitis was observed in the A-Part Gel group (6.5%) compared to the control group (13.8%).
• Anastomotic leakage rates were similar between groups.
• Adverse event rates were slightly lower in the A-Part Gel group, and adhesion rates were comparable.

Conclusions:

• A-Part Gel demonstrates safety for adhesion prophylaxis following abdominal wall surgery.
• The study did not find a significant reduction in postoperative peritoneal adhesions compared to the control group.
• Limitations include small sample size and incomplete incision coverage, suggesting the need for further investigation.